Business Wire · PFE · October 24, 2026

Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026

Get the app for more

Explore stock news, insights and company research.